Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Acquisitions & Divestments (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $132.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 57.43% to $132.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $462.3 million, a 2.71% increase, with the full-year FY2025 number at $462.3 million, up 2.71% from a year prior.
  • Change in Acquisitions & Divestments was $132.1 million for Q4 2025 at Nuvation Bio, up from $78.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $244.2 million in Q2 2023 to a low of $78.5 million in Q3 2025.
  • A 3-year average of $135.4 million and a median of $123.7 million in 2024 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: crashed 53.88% in 2024, then skyrocketed 57.43% in 2025.
  • Nuvation Bio's Change in Acquisitions & Divestments stood at $181.9 million in 2023, then plummeted by 53.88% to $83.9 million in 2024, then soared by 57.43% to $132.1 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Change in Acquisitions & Divestments are $132.1 million (Q4 2025), $78.5 million (Q3 2025), and $136.7 million (Q2 2025).